Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tabassome Simon

Showing results (231-240 of 272) with videos related to

Pageof 28
Sort By:
European Journal of Heart Failure|August 30, 2024
Burst steroid therapy for acute heart failure: The CORTAHF randomized, open-label, pilot trialGad Cotter, Beth A Davison, Yonathan Freund, et al.
JAMA|December 7, 2021
Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism: A Randomized Clinical TrialYonathan Freund, Anthony Chauvin, Sonia Jimenez, et al.
JAMA|October 28, 2010
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysisJessica L Mega, Tabassome Simon, Jean-Philippe Collet, et al.
JAMA Internal Medicine|June 3, 2025
Transfusion Strategy Effect on Quality of Life in Patients With Myocardial Infarction and Anemia: A Secondary Analysis of the MINT Randomized Clinical TrialMicah T Prochaska, Gerard T Portela, Maria Mori Brooks, et al.
European Heart Journal. Acute Cardiovascular Care|October 11, 2021
Diuretic vs. placebo in intermediate-risk acute pulmonary embolism: a randomized clinical trialPascal Lim, Clément Delmas, Olivier Sanchez, et al.
Archives of Cardiovascular Diseases|October 29, 2015
Management of Takotsubo cardiomyopathy in non-academic hospitals in France: The Observational French SyndromEs of TakoTsubo (OFSETT) studyKomlavi Yayehd, N'kenon W N'da, Loïc Belle, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 25, 2022
Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analysesIsabelle Durand-Zaleski, Gregory Ducrocq, Maroua Mimouni, et al.
Transfusion|November 27, 2025
Transfusion-related adverse events in patients with restrictive or liberal transfusion strategy. An analysis of the MINT trialShahab Ghafghazi, Lynne Uhl, Brandon Herbert, et al.
Circulation|August 29, 2017
Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015Etienne Puymirat, Tabassome Simon, Guillaume Cayla, et al.
Annals of Surgery|October 22, 2019
Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years' Follow-up Results of the Greccar-6 Randomized Multicenter TrialJérémie H Lefèvre, Laurent Mineur, Marine Cachanado, et al.
Pageof 28

Showing results (231-240 of 272) with videos related to

Sort By:
Pageof 28
European Journal of Heart Failure|August 30, 2024
Burst steroid therapy for acute heart failure: The CORTAHF randomized, open-label, pilot trialGad Cotter, Beth A Davison, Yonathan Freund, et al.
JAMA|December 7, 2021
Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism: A Randomized Clinical TrialYonathan Freund, Anthony Chauvin, Sonia Jimenez, et al.
JAMA|October 28, 2010
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysisJessica L Mega, Tabassome Simon, Jean-Philippe Collet, et al.
JAMA Internal Medicine|June 3, 2025
Transfusion Strategy Effect on Quality of Life in Patients With Myocardial Infarction and Anemia: A Secondary Analysis of the MINT Randomized Clinical TrialMicah T Prochaska, Gerard T Portela, Maria Mori Brooks, et al.
European Heart Journal. Acute Cardiovascular Care|October 11, 2021
Diuretic vs. placebo in intermediate-risk acute pulmonary embolism: a randomized clinical trialPascal Lim, Clément Delmas, Olivier Sanchez, et al.
Archives of Cardiovascular Diseases|October 29, 2015
Management of Takotsubo cardiomyopathy in non-academic hospitals in France: The Observational French SyndromEs of TakoTsubo (OFSETT) studyKomlavi Yayehd, N'kenon W N'da, Loïc Belle, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 25, 2022
Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analysesIsabelle Durand-Zaleski, Gregory Ducrocq, Maroua Mimouni, et al.
Transfusion|November 27, 2025
Transfusion-related adverse events in patients with restrictive or liberal transfusion strategy. An analysis of the MINT trialShahab Ghafghazi, Lynne Uhl, Brandon Herbert, et al.
Circulation|August 29, 2017
Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015Etienne Puymirat, Tabassome Simon, Guillaume Cayla, et al.
Annals of Surgery|October 22, 2019
Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years' Follow-up Results of the Greccar-6 Randomized Multicenter TrialJérémie H Lefèvre, Laurent Mineur, Marine Cachanado, et al.
Pageof 28